Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8610)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2017 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol 2017; 23(29): 5324-5332 [PMID: 28839432 DOI: 10.3748/wjg.v23.i29.5324] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i29/5324.htm |
| Number | Citing Articles |
| 1 |
Tingting Wang, Ning Chen, Weixia Ren, Fangfang Liu, Fangfang Gao, Lei Ye, Ying Han, Yujun Zhang, Yulan Liu. Integrated analysis of circRNAs and mRNAs expression profile revealed the involvement of hsa_circ_0007919 in the pathogenesis of ulcerative colitis. Journal of Gastroenterology 2019; 54(9): 804 doi: 10.1007/s00535-019-01585-7
|
| 2 |
Yu Zheng Wu, Kathy Yuen Yee Chan, Kam Tong Leung, Hugh Simon Lam, Yuk Him Tam, Kim Hung Lee, Karen Li, Pak Cheung Ng. The miR‐223/nuclear factor I‐A axis regulates inflammation and cellular functions in intestinal tissues with necrotizing enterocolitis. FEBS Open Bio 2021; 11(7): 1907 doi: 10.1002/2211-5463.13164
|
| 3 |
Fabia Fricke, Veronika Mussack, Dominik Buschmann, Ingrid Hausser, Michael Pfaffl, J�rgen Kopitz, Johannes Gebert. TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4859
|
| 4 |
Jie Peng, Susu Shi, Juan Yu, Jianli Liu, Haixiang Wei, Haixia Song, Shaoqiang Wang, Zhejie Li, Shujin He, Lei Li, Hongyan Zhang, Zhizhen Yan, Ran Zhao, Yukun Liu, Yanrong Liu, Junjun Li, Renya Zhang, Wei Wang. miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02403-y
|
| 5 |
Lijie Lai, Hanyang Li, Qi Feng, Jun Shen, Zhihua Ran. Multi-factor mediated functional modules identify novel classification of ulcerative colitis and functional gene panel. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85000-3
|
| 6 |
Xiangjun Xiao, Xiangbing Mao, Daiwen Chen, Bing Yu, Jun He, Hui Yan, Jianping Wang. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.868229
|
| 7 |
Takahiko Toyonaga, Masayuki Saruta. Role of microRNAs in the Pathophysiology of Ulcerative Colitis. Immuno 2021; 1(4): 558 doi: 10.3390/immuno1040039
|
| 8 |
Peeyush Kumar, Saurabh Kedia, Vineet Ahuja. Target potential of miRNAs in ulcerative colitis: what do we know?. Expert Opinion on Therapeutic Targets 2024; 28(10): 829 doi: 10.1080/14728222.2024.2408423
|
| 9 |
Chengyin Li, Rhea E. Sullivan, Dongxiao Zhu, Steven D. Hicks. Putting the “mi” in omics: discovering miRNA biomarkers for pediatric precision care. Pediatric Research 2023; 93(2): 316 doi: 10.1038/s41390-022-02206-5
|
| 10 |
Guotao Wu, Dan Zhang, Lichao Yang, Qiang Wu, Lianwen Yuan. MicroRNA-200c-5p targets NIMA Related Kinase 7 (NEK7) to inhibit NOD-like receptor 3 (NLRP3) inflammasome activation, MODE-K cell pyroptosis, and inflammatory bowel disease in mice. Molecular Immunology 2022; 146: 57 doi: 10.1016/j.molimm.2022.03.121
|
| 11 |
Ting Li, Weidong Liu, Wenjia Hui, Tian Shi, Huan Liu, Yan Feng, Feng Gao, Yang Mi. Integrated Analysis of Ulcerative Colitis Revealed an Association between PHLPP2 and Immune Infiltration. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4983471
|
| 12 |
Mikkel Malham, Jaslin P. James, Christian Jakobsen, Estrid Hoegdall, Kim Holmstroem, Vibeke Wewer, Boye S. Nielsen, Lene B. Riis. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis. Aging 2021; 13(5): 6359 doi: 10.18632/aging.202715
|
| 13 |
Na Lei, Pengfei Kong, Simin Chen, Qiuxiao Wang, Xuegui Tang, Fang Liu. Upregulated NORAD is implicated in apoptosis, inflammation, and oxidative stress in ulcerative colitis through the nuclear factor-κappaB signaling. European Journal of Gastroenterology & Hepatology 2022; 34(6): 630 doi: 10.1097/MEG.0000000000002370
|
| 14 |
Swati Valmiki, Vineet Ahuja, Niti Puri, Jaishree Paul. miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway. Frontiers in Medicine 2020; 6 doi: 10.3389/fmed.2019.00313
|
| 15 |
Samy A. Abdelazim, Olfat G. Shaker, Omaima Ali, Mai El-Tawil, Mahmoud A. Senousy. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn’s disease: Correlations with disease activity, extent, and location. Pathology - Research and Practice 2023; 252: 154910 doi: 10.1016/j.prp.2023.154910
|
| 16 |
Vishal Khatri, Ramaswamy Kalyanasundaram. Therapeutic implications of inflammasome in inflammatory bowel disease. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002622R
|
| 17 |
Jing Zhou, Jialing Liu, Yangyang Gao, Liwei Shen, Sheng Li, Simin Chen. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.707776
|
| 18 |
Huixia Zhang, Fangbin Zhang, Wei Li. Function of intestinal barrier protected by regulating the miR‐199a‐3p in ulcerative colitis: Modulation of IL‐23/IL‐17A axis. Fundamental & Clinical Pharmacology 2021; 35(5): 852 doi: 10.1111/fcp.12650
|
| 19 |
Rashida Naseem, Samiah Shahid, Wajeehah Shahid, Ghulam Abbas. Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241286283
|
| 20 |
Edda Russo, Lorenzo Cinci, Leandro Di Gloria, Simone Baldi, Mario D’Ambrosio, Giulia Nannini, Elisabetta Bigagli, Lavinia Curini, Marco Pallecchi, Donato Andrea Arcese, Stefano Scaringi, Cecilia Malentacchi, Gianluca Bartolucci, Matteo Ramazzotti, Cristina Luceri, Amedeo Amedei, Francesco Giudici. Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.886468
|
| 21 |
Shivnarayan Dhuppar, Gopal Murugaiyan. miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease. Trends in Immunology 2022; 43(11): 917 doi: 10.1016/j.it.2022.09.003
|
| 22 |
Cinderella A. Fahmy, Amira M. Gamal-Eldeen, Enas A. El-Hussieny, Bassem M. Raafat, Nayra S. Mehanna, Roba M. Talaat, Mohamed T. Shaaban. Bifidobacterium longumSuppresses Murine Colorectal Cancer through the Modulation of oncomiRs and Tumor Suppressor miRNAs. Nutrition and Cancer 2019; 71(4): 688 doi: 10.1080/01635581.2019.1577984
|
| 23 |
Terutaka Kodama, Yuko Togashi, Naomi Matsutani, Seiichiro Kurashige, Toyohiko Aoki, Yasuteru Otagiri. Fecal microRNA223 as an indicator of recovery in chronic DSS colitis model in rats. Fundamental Toxicological Sciences 2022; 9(3): 103 doi: 10.2131/fts.9.103
|
| 24 |
Samira Nasiri Kolahi, Zivar Salehi, Soheila Talesh Sasani, Farhad Mashayekhi, Keyvan Aminian. Polymorphisms of miR-146a and susceptibility to ulcerative colitis risk: a case-control study. Nucleosides, Nucleotides & Nucleic Acids 2023; 42(3): 206 doi: 10.1080/15257770.2022.2118768
|
| 25 |
Iuliana Samoilă, Sorina Dinescu, Marieta Costache. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis. Cells 2020; 9(7): 1647 doi: 10.3390/cells9071647
|
| 26 |
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865777
|
| 27 |
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen. Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis. Gut 2023; 72(11): 2068 doi: 10.1136/gutjnl-2023-329689
|
| 28 |
Zeinab Amini-Farsani, Mahtab Yadollahi-Farsani, Samaneh Arab, Fatemeh Forouzanfar, Mitra Yadollahi, Samira Asgharzade. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways. International Immunopharmacology 2021; 100: 108071 doi: 10.1016/j.intimp.2021.108071
|
| 29 |
Zhenfei Wu, You Tian, Chen Wang, Jie Zhang, Jinhan Lin. MiRNA-192-5p-targeted activated leukocyte cell adhesion molecule improved inflammatory injury of neonatal necrotizing enterocolitis. Pediatric Surgery International 2024; 40(1) doi: 10.1007/s00383-024-05713-0
|
| 30 |
Jie Guo, Mengfan Liao, Jun Wang. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00771-6
|
| 31 |
Alexandria J. Shumway, Michael T. Shanahan, Emilie Hollville, Kevin Chen, Caroline Beasley, Jonathan W. Villanueva, Sara Albert, Grace Lian, Moises R. Cure, Matthew Schaner, Lee-Ching Zhu, Surekha Bantumilli, Mohanish Deshmukh, Terrence S. Furey, Shehzad Z. Sheikh, Praveen Sethupathy. Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn’s disease. JCI Insight 2024; 9(4) doi: 10.1172/jci.insight.168800
|
| 32 |
Carolina Battistini, Rafael Ballan, Marcos Edgar Herkenhoff, Susana Marta Isay Saad, Jun Sun. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2020; 22(1): 362 doi: 10.3390/ijms22010362
|
| 33 |
Horia Minea, Ana-Maria Singeap, Manuela Minea, Simona Juncu, Cristina Muzica, Catalin Victor Sfarti, Irina Girleanu, Stefan Chiriac, Ioana Diandra Miftode, Carol Stanciu, Anca Trifan. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(15): 8420 doi: 10.3390/ijms25158420
|
| 34 |
Małgorzata Guz, Tomasz Dworzański, Witold Jeleniewicz, Marek Cybulski, Joanna Kozicka, Andrzej Stepulak, Krzysztof Celiński, Hai-Feng Pan. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4250329
|
| 35 |
Hong Liu, Yi-Biao Wang. Systematic large-scale meta-analysis identifies miRNA-429/200a/b and miRNA-141/200c clusters as biomarkers for necrotizing enterocolitis in newborn. Bioscience Reports 2019; 39(9) doi: 10.1042/BSR20191503
|
| 36 |
Rajan Singh, Se Eun Ha, Han Sung Park, Sushmita Debnath, Hayeong Cho, Gain Baek, Tae Yang Yu, Seungil Ro. Sustained Effectiveness and Safety of Therapeutic miR-10a/b in Alleviating Diabetes and Gastrointestinal Dysmotility without Inducing Cancer or Inflammation in Murine Liver and Colon. International Journal of Molecular Sciences 2024; 25(4): 2266 doi: 10.3390/ijms25042266
|
| 37 |
Hussein Mahmoud Saad, Ezzat Ali, Nahed Baddour, Mohamed Eid Ibrahim, Eman Tayae. Serum expression of microRNA-16 in a cohort of Egyptian patients with ulcerative colitis and its correlation with disease extent and severity. Journal of Coloproctology 2020; 40(03): 253 doi: 10.1016/j.jcol.2020.05.013
|
| 38 |
Soudeh Ghafouri-Fard, Reyhane Eghtedarian, Mohammad Taheri. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease. Biomedicine & Pharmacotherapy 2020; 129: 110507 doi: 10.1016/j.biopha.2020.110507
|
| 39 |
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer. International Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
|
| 40 |
Yasaman Pourmehran, Farzad Sadri, Seyede Fatemeh Hosseini, Yaser Mohammadi, Zohreh Rezaei. Exploring the influence of non-coding RNAs on NF-κB signaling pathway regulation in ulcerative colitis. Biomedicine & Pharmacotherapy 2024; 179: 117390 doi: 10.1016/j.biopha.2024.117390
|
| 41 |
Weronika Kurowska, Ewa Kuca-Warnawin, Anna Radzikowska, Michał Jakubaszek, Maria Maślińska, Brygida Kwiatkowska, Włodzimierz Maśliński. Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study. Rheumatology 2018; 56(1): 10 doi: 10.5114/reum.2018.74742
|
| 42 |
Wei Qiu, Francis Akanyibah, Yuxuan Xia, Dickson Ocansey, Fei Mao, Yuelan Liang. Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review). International Journal of Molecular Medicine 2024; 55(2) doi: 10.3892/ijmm.2024.5474
|
| 43 |
Mahvash Ghorbani, Alireza Mahmoudian, Seyyed Meysam Abtahi Froushani, Abdolghaffar Ownagh, Amir Tokmahchi. Lactobacillus Acidophilus Regulates the Expression of MicroRNAs and Ameliorates the Symptoms of Acid-induced Ulcerative Colitis in Rats. Journal of Advances in Medical and Biomedical Research 2023; 31(144): 64 doi: 10.30699/jambs.31.144.64
|
| 44 |
Ineke L. Tan, Rodrigo Coutinho de Almeida, Rutger Modderman, Anna Stachurska, Jackie Dekens, Donatella Barisani, Caroline R. Meijer, María Roca, Eva Martinez-Ojinaga, Raanan Shamir, Renata Auricchio, Ilma R. Korponay-Szabó, Gemma Castillejo, Hania Szajewska, Sibylle Koletzko, Alexandra Zhernakova, Vinod Kumar, Yang Li, Marijn C. Visschedijk, Rinse K. Weersma, Riccardo Troncone, M. Luisa Mearin, Cisca Wijmenga, Iris Jonkers, Sebo Withoff. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.734763
|
| 45 |
Lisha Jiang, Lingling Zhang, Can Rui, Xia Liu, Zhiyuan Mao, Lina Yan, Ting Luan, Xinyan Wang, Ying Wu, Ping Li, Xin Zeng. The role of the miR1976/CD105/integrin αvβ6 axis in vaginitis induced by Escherichia coli infection in mice. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50902-w
|
| 46 |
Keyur Donda, Benjamin A Torres, Akhil Maheshwari. Non-coding RNAs in Neonatal Necrotizing Enterocolitis. Newborn 2022; 1(1): 120 doi: 10.5005/jp-journals-11002-0012
|
| 47 |
Shuai Peng, Lei Shen, Xiaoyun Yu, Jing Wu, Lanlan Zha, Yuan Xia, Hesheng Luo. miR-200a attenuated oxidative stress, inflammation, and apoptosis in dextran sulfate sodium-induced colitis through activation of Nrf2. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1196065
|
| 48 |
Xiaodong Zhu, Ye Zhu, Caijuan Li, Jianbo Yu, DanDan Ren, Shou Qiu, Ying Nie, Xin Yu, Xiaoyan Xu, Wei Zhu. 1,25‑Dihydroxyvitamin D regulates macrophage polarization and ameliorates experimental inflammatory bowel disease by suppressing miR-125b. International Immunopharmacology 2019; 67: 106 doi: 10.1016/j.intimp.2018.12.015
|
| 49 |
Tianle He, Jiaying Ma, Shuai Liu, Boyan Ma, Jingtao You, Jingjun Wang, Mengmeng Li, Wei Wang, Ya Jing Wang, Shengli Li, Zhijun Cao. MicroRNA‐microbiota interactions: Emerging strategies for modulating intestinal homeostasis and enhancing host health. iMetaOmics 2025; 2(1) doi: 10.1002/imo2.57
|